Article

Alcon acquires ophthalmic division of SMI

Addition of SensoMotoric Instruments technology adds capabilities in ocular surgery guidance technology to Alcon's existing global cataract portfolio.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) CCOI Myopia Workshop: Michael X. Repka, MD, MBA, on building consensus and future directions
Related Content
Q&A: Amir Kashani on biomarkers for Alzheimer disease
September 9th 2025

Q&A: Amir Kashani on biomarkers for Alzheimer disease

3 Things You Should Know About the GA Pipeline
September 9th 2025

NK Insights: An Interactive Corneal Sensitivity Testing Workshop

Celltrion announces phase 3 trial data for EYDENZELT
September 9th 2025

Celltrion announces phase 3 trial data for EYDENZELT

3 Things You Should Know About the GA Pipeline
September 9th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

(Image credit: AdobeStock/FourLeafLover) Glaucoma-focused session with Angelo P. Tanna, MD, launches Northwestern University’s “Dinner with the Experts” series
September 9th 2025

Glaucoma-focused session with Angelo P. Tanna, MD, launches Northwestern University’s “Dinner with the Experts” series

Alcon completes acquisition of LumiThera
September 9th 2025

Alcon completes acquisition of LumiThera

© 2025 MJH Life Sciences

All rights reserved.